Clinical impact and disparities in mortality and antimicrobial resistance between Gram-negative and Gram-positive bacteria in cirrhotic abdominal infections: a meta-analysis

肝硬化腹部感染中革兰氏阴性菌和革兰氏阳性菌的临床影响及死亡率和抗菌素耐药性差异:一项荟萃分析

阅读:2

Abstract

BACKGROUND: Bacterial infections are a leading cause of morbidity and mortality in patients with liver cirrhosis. Shifts in pathogen distribution and the rise of multidrug-resistant (MDR) organisms complicate clinical management, yet the relative impact of Gram-negative versus Gram-positive infections remains uncertain. OBJECTIVE: To compare the prevalence, mortality, and MDR rates between Gram-negative and Gram-positive bacterial pathogens in cirrhotic abdominal infections. METHODS: A systematic review and meta-analysis was conducted in accordance with PRISMA 2020 guidelines. PubMed, Web of Science, and CNKI were searched for studies published from January 2015 to December 2024. Eligible cohort studies included adult cirrhotic patients with documented bacterial infections and reported outcomes of infection distribution, mortality, or MDR rates. Study quality was assessed using Cochrane Risk of Bias Assessment. Pooled effect sizes were calculated using RevMan 5.4, with heterogeneity assessed by the I (2) statistic and sensitivity analyses performed by sequential study exclusion. RESULTS: Five cohort studies involving 580 cirrhotic patients were included. Gram-negative bacteria were more prevalent than Gram-positive bacteria (risk difference 0.15, 95% CI 0.09-0.20; I (2) = 28%). Mortality was higher in Gram-negative infections (risk difference 0.10, 95% CI 0.01-0.20; I (2) = 0%). Gram-negative organisms demonstrated a nearly threefold higher risk of MDR compared with Gram-positive organisms (risk ratio 2.94, 95% CI 1.87-4.64; I (2) = 25%). No significant publication bias was detected. CONCLUSION: Gram-negative bacteria remain the most frequent causes of infection in cirrhosis and are associated with higher mortality and the rate of MDR when compared to Gram-positive pathogens. Subgroup results support an increase in the proportion of Gram-positive SBP, related to fluoroquinolone prophylaxis and invasive procedures. Gram-negative predominance is greater in SBP than non-SBP. ICU patients displayed a significant higher proportion of Gram-positive organisms and a higher risk of Gram-negative MDR, and reduced mortality differences in relationship with a prevalent ACLF/sepsis physiopathology.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。